Published in Biotech Law Weekly, July 2nd, 2010
"The American Red Cross and the Food and Drug Administration share a common goal of the safest blood supply possible for this country. We appreciate the fact that the FDA has recognized that the Red Cross is making progress in improving compliance, but are disappointed that the FDA believed it necessary to fine us for prior violations dating back several years. The FDA also acknowledged no evidence that the Red Cross violations endangered any patients.
"The Red Cross is fully committed to meeting all FDA standards, and we have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.